Literature DB >> 6199308

Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody.

D L Brawner, J E Cutler.   

Abstract

The expression of a surface immunodeterminant of Candida albicans was investigated with an agglutinating immunoglobulin M monoclonal antibody. The 96 strains of C. albicans tested, of which 76% were recent clinical isolates, were capable of expressing the antigen. The antigen was also produced by strains of Candida tropicalis and Torulopsis glabrata, but not by other yeast species. Expression of the surface immunodeterminant in C. albicans varied as a function of growth as indicated by agglutinin reactions and indirect immunofluorescence tests. When yeast cells were tested with the agglutinin, three patterns of reactivity were observed. In general, cells in the early logarithmic phase were less reactive than cells in the mid-logarithmic phase. Antigen expression, as determined by agglutinin reactivity, was also influenced by the nutritional composition of the growth medium, and in general, cells from broth cultures were usually more reactive than cells grown on solid media. The antigen was solubilized from the cell surface of C. albicans by hot 1 M NaCl. These water-soluble extracts were capable of binding antibody, and a single precipitin band formed when soluble antigen was reacted with the monoclonal antibody in an Ouchterlony double-diffusion test. Whole cell preparations and hot NaCl extracts from yeast strains which did not agglutinate when mixed with the antibody also did not absorb the agglutinin from solution. These data indicate that the expression of surface antigens on C. albicans is a dynamic process which may be influenced by a number of environmental factors. The use of monoclonal antibodies may allow characterization of surface antigens presented to the host during candidiasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199308      PMCID: PMC264279          DOI: 10.1128/iai.43.3.966-972.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis.

Authors:  M L Schulking; W H Adler; W A Altemeier; E M Ayoub
Journal:  Cell Immunol       Date:  1972-04       Impact factor: 4.868

2.  Serologic aspects on yeast classification.

Authors:  T Tsuchiya; Y Fukazawa; M Taguchi; T Nakase; T Shinoda
Journal:  Mycopathol Mycol Appl       Date:  1974-08-30

3.  Passive immunization of mice against Candida albicans.

Authors:  S Mourad; L Friedman
Journal:  Sabouraudia       Date:  1968-02

4.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

5.  Use of potato flakes agar in clinical mycology.

Authors:  M G Rinaldi
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

6.  Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.

Authors:  P Y Paterson; R Semo; G Blumenschein; J Swelstad
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

7.  Functional aspects of a second mechanism of candidacidal activity by human neutrophils.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis.

Authors:  M Manning; T G Mitchell
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  Rapid identification of yeasts by serological methods: a combined serological and biological method.

Authors:  M Taguchi; M Tsukiji; T Tsuchiya
Journal:  Sabouraudia       Date:  1979-09

10.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

View more
  40 in total

Review 1.  Cytological immunodetection of yeast glycoprotein secretion.

Authors:  J C Cailliez; D Poulain; D W Mackenzie; L Polonelli
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 2.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

3.  Evaluation of a gold-silver staining method for detection and identification of Candida species by light microscopy.

Authors:  J C Cailliez; A Boudrissa; D W Mackenzie; D Poulain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

4.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 5.  Candida identification: a journey from conventional to molecular methods in medical mycology.

Authors:  Mohammad Zubair Alam; Qamre Alam; Asif Jiman-Fatani; Mohammad Amjad Kamal; Adel M Abuzenadah; Adeel G Chaudhary; Mohammad Akram; Absarul Haque
Journal:  World J Microbiol Biotechnol       Date:  2014-01-01       Impact factor: 3.312

6.  Caveats in the investigation of form-specific molecules of Candida albicans.

Authors:  D L Brawner; J E Cutler; W L Beatty
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

7.  A monoclonal antibody to a cell wall component of Candida albicans.

Authors:  V Hopwood; D Poulain; B Fortier; G Evans; A Vernes
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

8.  Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata.

Authors:  K C Hazen; B J Plotkin; D M Klimas
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 9.  New developments in the diagnosis of opportunistic fungal infection.

Authors:  V Hopwood; D W Warnock
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

10.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.